{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:16:55Z","timestamp":1792855015563,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deutsches Krebsforschungszentrum (DKFZ)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>While several countries reported an impact of the coronavirus disease (COVID-19) pandemic on cancer incidence in 2020, little is known about trends in the following years. This study examined changes in cancer incidence in Baden-W\u00fcrttemberg between 2015 and 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from the Baden-W\u00fcrttemberg Cancer Registry were used to calculate age-standardized and age-specific incidence rates for all cancers combined and for colorectal, lung, prostate, and breast cancer. Incidence rates for 2020 to 2023 were compared with those from a pre-pandemic reference period (2017\u20132019) and with expected rates based on modeled trends between 2015 and 2019 using standardized incidence ratios (SIRs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among men, the age-standardized overall cancer incidence declined significantly from 734.0 per 100,000 in 2019 to 672.9\u2013681.7 during 2020\u20132023. In women, incidence declined from 542.2 in 2019 to 504.3\u2013524.4, with statistically significant reductions in 2022 and 2023. Compared to 2017\u20132019 levels, 14,214 fewer cases (-5.5%) were diagnosed in 2020\u20132023; relative to model-based expectations, 19,525 fewer cases (-7.6%) were reported. Site-specific analyses showed significantly lower colorectal cancer incidence in both sexes from 2020 onwards (SIRs: 0.81\u20130.90). For men, part of this decline may reflect a pre-existing downward trend. No significant deviations were found for lung and prostate cancer. Female breast cancer incidence was significantly lower only in 2020 (SIR: 0.93).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Cancer incidence in Baden-W\u00fcrttemberg remained consistently below pre-pandemic and expected levels from 2020 through 2023. Further research is warranted to disentangle potential contributing factors, including post-pandemic effects, competing mortality risks, and migration-related population changes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00432-025-06349-w","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:27:33Z","timestamp":1761046053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cancer incidence trends in Baden-W\u00fcrttemberg (Southwest Germany) during and after the COVID-19 pandemic (2020\u20132023)"],"prefix":"10.1007","volume":"151","author":[{"given":"Lina","family":"Jansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Bergbold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Arndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"6349_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10654-022-00946-6","volume":"38","author":"M Angelini","year":"2023","unstructured":"Angelini M, Teglia F, Astolfi L, Casolari G, Boffetta P (2023) Decrease of cancer diagnosis during COVID-19 pandemic: a systematic review and meta-analysis. Eur J Epidemiol 38:31\u201338. https:\/\/doi.org\/10.1007\/s10654-022-00946-6","journal-title":"Eur J Epidemiol"},{"key":"6349_CR2","doi-asserted-by":"publisher","first-page":"1370862","DOI":"10.3389\/fonc.2024.1370862","volume":"14","author":"NL Barclay","year":"2024","unstructured":"Barclay NL, Pineda Moncus\u00ed M, J\u00f6dicke AM et al (2024) The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study. Front Oncol 14:1370862. https:\/\/doi.org\/10.3389\/fonc.2024.1370862","journal-title":"Front Oncol"},{"key":"6349_CR3","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1002\/ijc.34847","volume":"154","author":"D Bennett","year":"2024","unstructured":"Bennett D, Murray I, Mitchell H, Gavin A, Donnelly D (2024) Impact of COVID-19 on cancer incidence, presentation, diagnosis, treatment and survival in Northern Ireland. Int J Cancer 154:1731\u20131744. https:\/\/doi.org\/10.1002\/ijc.34847","journal-title":"Int J Cancer"},{"key":"6349_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3238\/arztebl.2016.0101","volume":"113","author":"H Brenner","year":"2016","unstructured":"Brenner H, Schrotz-King P, Holleczek B, Katalinic A, Hoffmeister M (2016) Declining bowel cancer incidence and mortality in Germany. Dtsch Arztebl Int 113:101\u2013106. https:\/\/doi.org\/10.3238\/arztebl.2016.0101","journal-title":"Dtsch Arztebl Int"},{"key":"6349_CR5","unstructured":"Statistisches Bundesamt (2025) Pressemitteilung Nr. N046 vom 1. September 2025, Wiesbaden, Germany (Accessed: 9 September 2025)."},{"key":"6349_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.32288","volume":"7","author":"T Burus","year":"2024","unstructured":"Burus T, Lei F, Huang B et al (2024) COVID-19 and rates of cancer diagnosis in the US. JAMA Netw Open 7:e2432288. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.32288","journal-title":"JAMA Netw Open"},{"key":"6349_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13690-024-01277-6","volume":"82","author":"P Chor\u0119za","year":"2024","unstructured":"Chor\u0119za P, Owczarek AJ, Kruk W, Chudek J (2024) The epidemiology of the most frequent cancers in Poland in 2015\u20132021 and the impact of the COVID-19 pandemic on cancer incidence. Arch Public Health 82:49. https:\/\/doi.org\/10.1186\/s13690-024-01277-6","journal-title":"Arch Public Health"},{"key":"6349_CR9","doi-asserted-by":"publisher","first-page":"14329","DOI":"10.1007\/s00432-023-05063-9","volume":"149","author":"KK De Santis","year":"2023","unstructured":"De Santis KK, Helmer S, Barnes B et al (2023) Impact of the COVID-19 pandemic on oncological care in Germany: rapid review. J Cancer Res Clin Oncol 149:14329\u201314340. https:\/\/doi.org\/10.1007\/s00432-023-05063-9","journal-title":"J Cancer Res Clin Oncol"},{"key":"6349_CR10","unstructured":"D\u00e9cieux JP, Ette A (2024) Kapitel 7.4.1. Soziodemografische Struktur der ukrainischen Gefl\u00fcchteten. In: Sozialbericht, Statistisches Bundesamt (Destatis), Wissenschaftszentrum Berlin f\u00fcr Sozialforschung (WZB), Bundesinstitut f\u00fcr Bev\u00f6lkerungsforschung (BiB) in Zusammenarbeit mit: Sozio-oekonomische Panel (SOEP) am Deutschen Institut f\u00fcr Wirtschaftsforschung (DIW Berlin), Frankfurt"},{"key":"6349_CR11","volume-title":"Tabakatlas Deutschland 2025","author":"Deutsches Krebsforschungszentrum","year":"2025","unstructured":"Deutsches Krebsforschungszentrum, Deutsche Krebshilfe (2025) Tabakatlas Deutschland 2025. Pabst Science Publishers, Lengerich"},{"key":"6349_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2023.102481","volume":"87","author":"AH Eijkelboom","year":"2023","unstructured":"Eijkelboom AH, de Munck L, Larsen M et al (2023) Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: a population-based study. Cancer Epidemiol 87:102481. https:\/\/doi.org\/10.1016\/j.canep.2023.102481","journal-title":"Cancer Epidemiol"},{"key":"6349_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00432-024-06019-3","volume":"150","author":"F Erdmann","year":"2024","unstructured":"Erdmann F, Wellbrock M, De Santis KK, Hubner J, Voigtlander S, Arndt V (2024) Impact of the COVID-19 pandemic on cancer diagnoses, oncological care and cancer patients in Germany: a report from the \u201cCOVID & Cancer\u201d workshop 2023 of the German Society for Epidemiology (DGEpi). J Cancer Res Clin Oncol 150:491. https:\/\/doi.org\/10.1007\/s00432-024-06019-3","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"6349_CR14","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.3390\/cancers15061753","volume":"15","author":"G Garrido-Cantero","year":"2023","unstructured":"Garrido-Cantero G, Longo F, Hern\u00e1ndez-Gonz\u00e1lez J et al (2023) Impact of the COVID-19 Pandemic on Cancer Diagnosis in Madrid (Spain) Based on the RTMAD Tumor Registry (2019\u20132021). Cancers (Basel) 15(6):1753. https:\/\/doi.org\/10.3390\/cancers15061753","journal-title":"Cancers (Basel)"},{"key":"6349_CR8","unstructured":"Gesundheitsforen Leipzig GmbH Evaluationsbericht Darmkrebs (2024) oKFE Auswertungsstelle. https:\/\/www.g-ba.de\/downloads\/17-98-5679\/2024-04-24_oKFE-Evaluationsbericht-Darmkrebs_GFL_2021-2022.pdf. Accessed 6 June 2025"},{"key":"6349_CR15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/jnci\/djae180","volume":"117","author":"N Howlader","year":"2025","unstructured":"Howlader N, Chen HS, Noone AM et al (2025) Impact of COVID-19 on 2021 cancer incidence rates and potential rebound from 2020 decline. J Natl Cancer Inst 117:507\u2013510. https:\/\/doi.org\/10.1093\/jnci\/djae180","journal-title":"J Natl Cancer Inst"},{"key":"6349_CR17","doi-asserted-by":"publisher","first-page":"24912","DOI":"10.1038\/s41598-024-75084-y","volume":"14","author":"L Jansen","year":"2024","unstructured":"Jansen L, Hermann S, Bergbold S, Arndt V (2024) Changes in breast cancer incidence and surgical treatment in Baden-W\u00fcrttemberg (Germany) during the COVID-19 pandemic. Sci Rep 14:24912. https:\/\/doi.org\/10.1038\/s41598-024-75084-y","journal-title":"Sci Rep"},{"key":"6349_CR18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2340\/1651-226x.2025.42079","volume":"64","author":"A Johansson","year":"2025","unstructured":"Johansson A, Skog A, Johannesen TB et al (2025) Changes in cancer incidence and stage during the COVID-19 pandemic in 2020\u20132021 in the Nordic countries. Acta Oncol 64:257\u2013266. https:\/\/doi.org\/10.2340\/1651-226x.2025.42079","journal-title":"Acta Oncol"},{"key":"6349_CR20","volume-title":"Jahresbericht Evaluation 2020. Deutsches Mammographie-Screening-Programm","author":"Kooperationsgemeinschaft Mammographie","year":"2022","unstructured":"Kooperationsgemeinschaft Mammographie (2022) Jahresbericht Evaluation 2020. Deutsches Mammographie-Screening-Programm. Kooperationsgemeinschaft Mammographie, Berlin"},{"key":"6349_CR19","volume-title":"Jahresbericht Evaluation 2021. Deutsches Mammographie-Screening-Programm","author":"Kooperationsgemeinschaft Mammographie","year":"2023","unstructured":"Kooperationsgemeinschaft Mammographie (2023) Jahresbericht Evaluation 2021. Deutsches Mammographie-Screening-Programm. Kooperationsgemeinschaft Mammographie, Berlin"},{"key":"6349_CR21","volume-title":"Jahresbericht Evaluation 2022. Deutsches Mammographie-Screening-Programm","author":"Kooperationsgemeinschaft Mammographie","year":"2024","unstructured":"Kooperationsgemeinschaft Mammographie (2024) Jahresbericht Evaluation 2022. Deutsches Mammographie-Screening-Programm. Kooperationsgemeinschaft Mammographie, Berlin"},{"key":"6349_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00761-023-01444-4","volume":"30","author":"K Kraywinkel","year":"2024","unstructured":"Kraywinkel K, Imhoff M, Voigtl\u00e4nder S, Stang A (2024) Krebsneuerkrankungen in Pandemiezeiten. Die Onkol 30:265\u2013272. https:\/\/doi.org\/10.1007\/s00761-023-01444-4","journal-title":"Die Onkol"},{"key":"6349_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-052777","volume":"11","author":"Y Mahamat-Saleh","year":"2021","unstructured":"Mahamat-Saleh Y, Fiolet T, Rebeaud ME et al (2021) Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies. BMJ Open 11:e052777. https:\/\/doi.org\/10.1136\/bmjopen-2021-052777","journal-title":"BMJ Open"},{"key":"6349_CR24","unstructured":"Mangiapane S, Zhu L, Kretschmann J, Czihal T, Stillfried D (2021a) Ver\u00e4nderung der vertrags\u00e4rztlichen Ver\u00e4nderung der vertrags\u00e4rztlichen Leistungsinanspruchnahme w\u00e4hrend der COVID-Krise: Tabellarischer Trendreport bis zum 1. Halbjahr 2022. https:\/\/www.zi.de\/fileadmin\/Downloads\/Service\/Publikationen\/Trendreport_7_Leistungsinanspruchnahme_COVID_2022-12-08.pdf (Accessed: 6 June 2025)."},{"key":"6349_CR25","unstructured":"Mangiapane S, Kretschmann J, Czihal T, Stillfried D (2021b) Zi-Trendreport zur vertrags\u00e4rztlichen Versorgung. Bundesweiter tabellarischer Report vom 1. Quartal 2021 bis zum 2. Quartal 2024 https:\/\/www.zi.de\/fileadmin\/Downloads\/Service\/Medien\/MI\/Zi-Trendreport_2024-Q2_FINAL.pdf (Accessed: 6 June 2025)."},{"key":"6349_CR26","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.mayocpiqo.2021.10.003","volume":"5","author":"M Mayo","year":"2021","unstructured":"Mayo M, Potugari B, Bzeih R, Scheidel C, Carrera C, Shellenberger RA (2021) Cancer screening during the COVID-19 pandemic: a systematic review and meta-analysis. Mayo Clin Proc Innov Qual Outcomes 5:1109\u20131117. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2021.10.003","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"6349_CR27","doi-asserted-by":"publisher","unstructured":"Michalski N, Reis M, Tetzlaff F et al. (2022) German Index of Socioeconomic Deprivation (GISD): Revision, Aktualisierung und Anwendungsbeispiele. Journal of Health Monitoring:24. https:\/\/doi.org\/10.25646\/10640","DOI":"10.25646\/10640"},{"key":"6349_CR28","unstructured":"Netzwerk Onkologische Spitzenzentren (2025) Das Netzwerk. https:\/\/www.ccc-netzwerk.de\/das-netzwerk\/mitglieder.html (Accessed: 9 September 2025)."},{"key":"6349_CR29","unstructured":"Referenzzentrum Mammographie S\u00fcdWest Universit\u00e4tsklinikum Gie\u00dfen und Marburg. https:\/\/referenzzentrum-suedwest.de\/qualitaetssicherung-mammographie-screening\/mammographie-screening-einheiten (Accessed: 9 September 2025)."},{"key":"6349_CR16","unstructured":"Robert Koch Institut (RKI) Corona-Zahlen: Aktuelle Statistik zu COVID-19. https:\/\/www.corona-in-zahlen.de\/. Accessed 14 July 2025"},{"key":"6349_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0316261","volume":"19","author":"A Romaszko-Wojtowicz","year":"2024","unstructured":"Romaszko-Wojtowicz A, Doboszy\u0144ska A, Piechnik A, Kuziemski K, Szplit D, Cofta S, Gli\u0144ska-Lewczuk K (2024) Impact of the COVID-19 pandemic on lung cancer diagnosis in northern Poland-addressing the COVID-19 debt. PLoS ONE 19:e0316261. https:\/\/doi.org\/10.1371\/journal.pone.0316261","journal-title":"PLoS ONE"},{"key":"6349_CR31","unstructured":"Statistics Office (2023) GENESIS-Online, Table AI014\u20131: Hospital Bed Density per 1,000 Inhabitants. [https:\/\/www-genesis.destatis.de\/genesis\/online] (Accessed: 9 September 2025)."},{"key":"6349_CR32","unstructured":"Statistisches Bundesamt Zensus 2022: 82,7 Millionen Einwohnerinnen und Einwohner. Pressemitteilung Nr. 44 vom 25. Juni 2024. https:\/\/www.destatis.de\/DE\/Presse\/Pressemitteilungen\/Zensus2022-Pressemitteilungen\/PM_zensus2022_44.html (Accessed: 28 July 2025)."},{"key":"6349_CR33","unstructured":"Statistisches Landesamt Baden-W\u00fcrttemberg Migration und Nationalit\u00e4t. Wanderungen der Ausl\u00e4nder\/-innen \u00fcber die Bundesgrenze in Baden-W\u00fcrttemberg (https:\/\/www.statistik-bw.de\/BevoelkGebiet\/MigrNation\/MN-Auslaender-WA.jsp) (Accessed: 14 July 2025)."},{"key":"6349_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-04707-0","author":"S Voigtl\u00e4nder","year":"2023","unstructured":"Voigtl\u00e4nder S, Hakimhashemi A, Grundmann N et al (2023) Impact of the COVID-19 pandemic on reported cancer diagnoses in Bavaria, Germany. J Cancer Res Clin Oncol. https:\/\/doi.org\/10.1007\/s00432-023-04707-0","journal-title":"J Cancer Res Clin Oncol"},{"key":"6349_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2340\/sju.v60.43172","volume":"60","author":"P Zaurito","year":"2025","unstructured":"Zaurito P, Garmo H, Gedeborg R et al (2025) Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study. Scand J Urol 60:93\u201396. https:\/\/doi.org\/10.2340\/sju.v60.43172","journal-title":"Scand J Urol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06349-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06349-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06349-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T19:38:55Z","timestamp":1765654735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-025-06349-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":35,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6349"],"URL":"https:\/\/doi.org\/10.1007\/s00432-025-06349-w","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Data collection within the Cancer Registry has been carried out according to state legislation of cancer registration. The study was conducted in accordance with the recommendations of the Declaration of Helsinki by the World Medical Association.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"300"}}